Location History:
- Berkeley, CA (US) (2017 - 2021)
- Emeryville, CA (US) (2016 - 2024)
Company Filing History:
9 out of 19 
2 out of 117 
1 out of 1 Years Active: 2016-2024
Title: Robyn M Barfield: Innovator in Antibody Conjugate Technologies
Introduction
Robyn M Barfield is a prominent inventor based in Emeryville, CA, with a remarkable portfolio of 12 patents. Her work primarily focuses on the development of antibody-maytansine conjugates, which have significant implications in targeted cancer therapies.
Latest Patents
Among her latest patents are the "Anti-CD22 antibody-maytansine conjugates and methods of use thereof," which provides innovative structures for anti-CD22 antibody-maytansine conjugates. This patent also encompasses methods for producing these conjugates and their applications in medical treatments. Another notable patent is the "Anti-HER2 antibody-maytansine conjugates and methods of use thereof," which similarly details the structures and production methods for anti-HER2 antibody-maytansine conjugates, highlighting their potential uses in therapeutic settings.
Career Highlights
Robyn has made significant contributions to the field through her work at Redwood Bioscience, Inc. and R.P. Scherer Technologies, Inc. Her expertise in antibody conjugate technologies has positioned her as a key figure in the biotechnology sector.
Collaborations
Throughout her career, Robyn has collaborated with notable professionals, including David Rabuka and Romas Alvydas Kudirka, enhancing her research and development efforts in the field.
Conclusion
Robyn M Barfield's innovative work in antibody-maytansine conjugates showcases her dedication to advancing cancer treatment technologies. Her contributions continue to impact the biotechnology industry significantly.